T. Rowe Price Investment Management Inc. Purchases 26,395 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

T. Rowe Price Investment Management Inc. increased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 0.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,002,648 shares of the company's stock after purchasing an additional 26,395 shares during the period. T. Rowe Price Investment Management Inc. owned 0.66% of GE HealthCare Technologies worth $234,748,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Cathy Pareto & Associates Inc. bought a new position in GE HealthCare Technologies in the 4th quarter valued at $670,000. Principal Financial Group Inc. boosted its position in GE HealthCare Technologies by 1.9% in the 3rd quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company's stock valued at $94,780,000 after buying an additional 19,010 shares during the last quarter. Everence Capital Management Inc. boosted its position in GE HealthCare Technologies by 118.2% in the 4th quarter. Everence Capital Management Inc. now owns 18,870 shares of the company's stock valued at $1,475,000 after buying an additional 10,220 shares during the last quarter. Apollon Wealth Management LLC boosted its position in GE HealthCare Technologies by 46.5% in the 4th quarter. Apollon Wealth Management LLC now owns 13,111 shares of the company's stock valued at $1,025,000 after buying an additional 4,160 shares during the last quarter. Finally, Sanibel Captiva Trust Company Inc. boosted its position in GE HealthCare Technologies by 139.9% in the 4th quarter. Sanibel Captiva Trust Company Inc. now owns 7,484 shares of the company's stock valued at $585,000 after buying an additional 4,364 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company's stock.

GE HealthCare Technologies Stock Down 0.2 %

Shares of GEHC traded down $0.14 during midday trading on Tuesday, hitting $67.93. The stock had a trading volume of 2,715,873 shares, compared to its average volume of 3,265,137. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The firm has a market cap of $31.10 billion, a price-to-earnings ratio of 15.66, a price-to-earnings-growth ratio of 3.19 and a beta of 1.14. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. The company has a 50 day simple moving average of $76.10 and a two-hundred day simple moving average of $81.91.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. On average, analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be paid a $0.035 dividend. The ex-dividend date of this dividend is Friday, April 25th. This represents a $0.14 annualized dividend and a yield of 0.21%. GE HealthCare Technologies's dividend payout ratio is 3.23%.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on GEHC shares. Citigroup raised their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research report on Thursday, February 13th. Wells Fargo & Company raised their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a research report on Friday, February 14th. Piper Sandler reduced their price target on GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 23rd. The Goldman Sachs Group upgraded GE HealthCare Technologies from a "neutral" rating to a "buy" rating and raised their price target for the stock from $85.00 to $100.00 in a research report on Tuesday, March 11th. Finally, BTIG Research set a $95.00 target price on GE HealthCare Technologies and gave the stock a "buy" rating in a report on Monday, April 14th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, GE HealthCare Technologies presently has a consensus rating of "Moderate Buy" and an average price target of $96.50.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.